The PFT systems market is experiencing growth due to the rising prevalence of respiratory disorders and the increasing demand for lung function assessments. Advances in spirometry, diffusion testing, and digital reporting are expected to support the adoption of pulmonary function testing. The need for early diagnosis and ongoing monitoring of conditions such as asthma and COPD is a significant driver of market demand.

The Spirometry Machine Market was valued at USD 2.8 billion in 2025 and is poised to grow from USD 3.

Learn how to confirm bronchial asthma with spirometry, reversibility testing, peak flow monitoring, FeNO, and other diagnostic tests.

The Spirometry Machine Market was valued at USD 2.8 billion in 2025 and is poised to grow from USD 3.

Background Post-COVID syndrome is common and associated with substantial morbidity, yet its pathophysiology and predictors of disease course remain incompletely understood. This study aimed to quantify symptom burden in patients attending a post-COVID outpatient clinic and to evaluate associations with pulmonary function parameters, exercise capacity, and circulating biomarkers. Methods The prospective CCHROMO cohort collects longitudinal clinical data, detailed pulmonary function testing, and blood samples from patients with persistent symptoms following SARS-CoV-2 infection, with planned follow-up of up to three years. We present an interim analysis of 253 patients contributing 561 study visits (median follow-up 273 days after COVID-19 diagnosis; interquartile range [IQR] 177–332). Assessments included standardized symptom questionnaires, spirometry, inspiratory muscle strength testing, cardiopulmonary exercise testing (CPET), and serum biomarker measurements reflecting inflammation as well as epithelial and endothelial injury. Results At study entry, the most prevalent symptoms were fatigue (84.6% reporting at least moderate severity), dyspnoea (70.3%), headache (69.8%), and neurocognitive impairment (66.4%). Spirometric values were within normal ranges in most participants. In contrast, reduced inspiratory muscle strength was observed in 54.8% of visits, and impaired exercise capacity on CPET in 28.8%. Correlations between symptom severity, pulmonary function, CPET parameters, and circulating biomarkers were weak. Serum club cell protein-16 (CC-16) levels were lower in patients with severe fatigue (median [IQR] 6.6 [4.7–8.4] ng/mL) compared with those without fatigue (7.6 [6.3–10.1] ng/mL; p = 0.039). Conclusions Patients with post-COVID syndrome show a high and persistent symptom burden, frequently accompanied by reduced inspiratory muscle strength and impaired exercise capacity despite preserved spirometry. Associations between symptoms, physiological measures, and biomarkers were weak and suggest heterogenous post-COVID manifestations. Trial registration German Clinical Trials Register (DRKS00022475, Date of Registration 2020-07-27).

Spirometry Market Size to gain 8.2% CAGR growth forecast by 2035, to reach USD 1.73 Billion. Spirometry industry research by Product, Technology, Application, End User and Region - forecast 2035

chronic lung disease, COPD, asthma, pulmonary function testing, resource-limited setting(s)

Medical College of Georgia described a new mobile low-dose CT unit that will offer free lung-cancer screening plus cardiac calcium scoring, diabetes A1c, COPD spirometry and other preventive tests for rural residents, with Starlink connectivity for same-day reads.

AI in COPD diagnosis can support case finding, spirometry interpretation and equity while GOLD 2026 highlights validation and guideline gaps

COPD explained, including breathlessness, chronic cough, phlegm, causes, spirometry, inhalers, pulmonary rehabilitation, flare-ups and when to seek help.

Objectives To develop and validate an automated 3D chest CT muscle segmentation model using an exploratory normalization method to discriminate normal, preserved ratio impaired spirometry (PRISm),…